Cystic fibrosis transmembrane conductance regulator (GenVec)

N/A

Report date: 2023/10/26 16:15:06

Base Information

Drug NameCystic fibrosis transmembrane conductance regulator (GenVec)

Drug Alias Name囊性纤维化跨膜传导调节因子-GenVecCystic fibrosis Tr gene therapy (recombinant adenovirus)AdGVCFTR.10

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionCFTR gene transference

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A